Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S5 from Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer
  1. Home
  2. Publications
  3. Supplementary Table S5 from Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer

Supplementary Table S5 from Ibrutinib and PD-1 Blockade Potentiate Mesothelin-Targeting CAR T-cell Therapy in Preclinical Models of Pancreatic Cancer

Authors:
  • AAAlexander Armstrong
    Alexander Armstrong
  • GPGraziella van der Plancke
    Graziella van der Plancke
  • SNSae Nishiguchi
    Sae Nishiguchi
  • DSDiego Salas-Benito
    Diego Salas-Benito
  • ABAmanda A. Bouffard
    Amanda A. Bouffard
  • SGSadie Goncalves
    Sadie Goncalves
  • AMAshlyn T. Merce
    Ashlyn T. Merce
  • CKChristopher Kelly
    Christopher Kelly
  • FBFilippo Birocchi
    Filippo Birocchi
  • SPSangwoo Park
    Sangwoo Park
  • MLMark B. Leick
    Mark B. Leick
  • NHNora Horick
    Nora Horick

Open Access
Publisher website
Google Scholar
  • 8 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.32604724
Abstract
Supplementary Table 5. The results of the statistical analysis used to assess additive vs synergistic effect of PD1-blockade antibody in combination with CAR-T cells is shown for Fig 6D.
Keywords
  • GASTROINTESTINAL CANCERS
  • PANCREATIC CANCER
  • IMMUNOTHERAPY
  • COMBINATION IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.